In the first quarter of 2025, the company reported revenues of $8,149 million, primarily driven by human therapeutics, with Europe as a key market. Operating expenses rose to $6,971 million,...
In the first quarter of 2025, the company celebrated a remarkable revenue increase of $63.2 million, reaching $230.7 million, primarily fueled by a surge in subscription revenue. Operating expenses were...
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
In the first quarter of 2025, the company celebrated a remarkable 61% revenue increase, fueled by advertising and content licensing. With a net income turnaround from a loss to nearly...
In the first quarter of 2025, the company experienced a revenue boost of $76.5 million, driven by increased rental income amid rising operating expenses. Despite a decline in net income,...
In the first quarter of 2025, the company experienced a notable rise in operating revenues, driven by increased rental income. However, rising operational costs, particularly for utilities, posed challenges. Management...
In the first quarter of 2025, the company celebrated a $76.5 million rise in operating revenues, driven by increased rental income. However, rising operating expenses, particularly for power and expansion,...
In the first quarter of 2025, MetLife experienced a rise in other revenues but faced a decrease in adjusted earnings due to higher interest expenses. Operating and total expenses declined...
In the first quarter of 2025, MetLife faced a mixed financial landscape. While other revenues grew from service contracts, adjusted earnings dipped due to rising interest expenses. Operating costs decreased...
In the first quarter of 2025, MetLife, Inc. saw a slight rise in adjusted earnings, driven by service contract fees, despite market challenges. Operating expenses and total costs decreased, showcasing...